Literature DB >> 528062

Cytotaxin receptors of neutrophils: evidence that F-methionyl peptides and pepstatin share a common receptor.

R D Nelson, S K Ackerman, V D Fiegel, M P Bauman, S D Douglas.   

Abstract

Pepstatin, a chemotactic microbial pentapeptide, competes with f-Met-Leu-[3H]Phe for binding to human neutrophils. Furthermore, porcine neutrophils, which neither specifically bind nor respond chemotactically to the synthetic f-methionyl peptides, also fail to respond chemotactically to pepstatin. These results suggest that pepstatin shares a receptor on the neutrophil with f-methionyl peptides, despite their completely different amino acid compositions. The specificity of this cytotaxin receptor may therefore be broader than expected and depend on ligand characteristics distinct from primary structure.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 528062      PMCID: PMC414717          DOI: 10.1128/iai.26.3.996-999.1979

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  17 in total

1.  Demonstration of a receptor on rabbit neutrophils for chemotactic peptides.

Authors:  S Aswanikumar; B Corcoran; E Schiffmann; A R Day; R J Freer; H J Showell; E L Becker
Journal:  Biochem Biophys Res Commun       Date:  1977-01-24       Impact factor: 3.575

2.  Demonstration of a specific neutrophil receptor for a cell-derived chemotactic factor.

Authors:  I Spilberg; J Mehta
Journal:  J Clin Invest       Date:  1979-01       Impact factor: 14.808

3.  Dissociation of the neutrophill functions of exocytosis and chemotaxis.

Authors:  I Spilberg; B Mandell; J Mehta; T Sullivan; L Simchowitz
Journal:  J Lab Clin Med       Date:  1978-08

4.  Pepstatin A--a human leukocyte chemoattractant.

Authors:  S K Ackerman; S D Douglas
Journal:  Clin Immunol Immunopathol       Date:  1979-10

5.  Effect of pepstatin on acid proteases.

Authors:  T Aoyagi; S Kunimoto; H Morishima; T Takeuchi; H Umezawa
Journal:  J Antibiot (Tokyo)       Date:  1971-10       Impact factor: 2.649

6.  Studies on the interaction between Streptomyces pepsin inhibitor and several acid proteinases by means of a zinc(II)-dye complex as a probe.

Authors:  H Nakatani; K Hiromi; S Satoi; K Oda; S murao
Journal:  Biochim Biophys Acta       Date:  1975-06-24

7.  Inhibition of cathepsin D-type proteinase of macrophages by pepstatin, a specific pepsin inhibitor, and other substances.

Authors:  M H McAdoo; A M Dannenberg; C J Hayes; S P James; J H Sanner
Journal:  Infect Immun       Date:  1973-04       Impact factor: 3.441

8.  Synthetic peptide chemotactic factors for neutrophils: the range of active peptides, their efficacy and inhibitory activity, and susceptibility of the cellular response to enzymes and bacterial toxins.

Authors:  P C Wilkinson
Journal:  Immunology       Date:  1979-03       Impact factor: 7.397

9.  Demonstration of specific C5a receptor on intact human polymorphonuclear leukocytes.

Authors:  D E Chenoweth; T E Hugli
Journal:  Proc Natl Acad Sci U S A       Date:  1978-08       Impact factor: 11.205

10.  Specific receptor sites for chemotactic peptides on human polymorphonuclear leukocytes.

Authors:  L T Williams; R Snyderman; M C Pike; R J Lefkowitz
Journal:  Proc Natl Acad Sci U S A       Date:  1977-03       Impact factor: 11.205

View more
  14 in total

1.  Regulation of neutrophil migratory function in burn injury by complement activation products.

Authors:  J S Solomkin; R D Nelson; D E Chenoweth; L D Solem; R L Simmons
Journal:  Ann Surg       Date:  1984-12       Impact factor: 12.969

2.  Two neutrophil populations in human blood with different chemotactic activities: separation and chemoattractant binding.

Authors:  L Harvath; E J Leonard
Journal:  Infect Immun       Date:  1982-05       Impact factor: 3.441

3.  Inhibition of mast-cell degranulation by chemotactic peptides.

Authors:  J M Gleisner; C A Ramthun; J C Houck
Journal:  Inflammation       Date:  1981-03       Impact factor: 4.092

4.  Feline polymorphonuclear leukocytes respond chemotactically to leukotriene B4 and activated serum but not to F-Met-Leu-Phe.

Authors:  G D Gray; G M Ohlmann; D R Morton; R G Schaub
Journal:  Agents Actions       Date:  1986-06

5.  Receptor blockade as a mechanism of deactivation of human neutrophils by pepstatin and formyl-Met-Leu-Phe.

Authors:  I Spilberg; J Mehta; M A Muniain; L Simchowitz; J Atkinson
Journal:  Inflammation       Date:  1984-03       Impact factor: 4.092

6.  Histamine release from human basophils by pepstatin A.

Authors:  G Marone; M Columbo; L Soppelsa; M Condorelli
Journal:  Agents Actions       Date:  1985-07

7.  Human neutrophil peptide receptors: mobilization mediated by phospholipase C.

Authors:  R D Nelson; V D Fiegel; D E Chenoweth
Journal:  Am J Pathol       Date:  1982-05       Impact factor: 4.307

8.  Inhibition of neutrophil chemotaxis by protease inhibitors. Differential effect of inhibitors of serine and thiol proteases.

Authors:  J B Barna; R R Kew
Journal:  Inflammation       Date:  1995-10       Impact factor: 4.092

9.  Receptor-directed inhibition of chemotactic factor-induced neutrophil hyperactivity by pyrazolon derivatives. Definition of a chemotactic peptide antagonist.

Authors:  C Dahinden; J Fehr
Journal:  J Clin Invest       Date:  1980-11       Impact factor: 14.808

10.  Characterization of the human neutrophil response to sex pheromones from Streptococcus faecalis.

Authors:  J A Ember; T E Hugli
Journal:  Am J Pathol       Date:  1989-04       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.